Adenocarcinoma  >>  Merck (MSD)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
Intron A (interferon α-2b) / Merck (MSD), Biogen           
          
            
             
tivantinib (ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD)           
          
            
             
Rencarex (girentuximab) / Heidelberg Pharma, Esteve, Merck (MSD)           
          
            
             
ViraferonPeg (peginterferon-α-2b) / Merck (MSD)           
          
            
             
Keytruda (pembrolizumab) / Merck (MSD)           
          
            
             
Lenvima (lenvatinib) / Eisai, Merck (MSD)